← Open Payments lookup

NGOZI UGWU: Open Payments

NPI 1184026684 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$386 in 18 payments from 9 companies in 2025. Trend: 2023 $667 · 2024 $352 · 2025 $386

Food & beverage: $386
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$76
ABBVIE INC.3$75
Alkermes, Inc.3$69
Takeda Pharmaceuticals U.S.A., Inc.2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Collegium Pharmaceutical, Inc.2$33
Lundbeck LLC1$25
Otsuka America Pharmaceutical, Inc.1$16
Teva Pharmaceuticals USA, Inc.1$15

Products named: INVEGA SUSTENNA, VRAYLAR, ARISTADA, TRINTELLIX, CAPLYTA, Jornay PM, REXULTI, ABILIFY ASIMTUFII.

Industry payments across NV — which companies pay providers there.